Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Budgets $110 Million For Broad Internal IT System Overhaul

Executive Summary

CMS is planning a broad initiative aimed at making the wealth of data it collects from Medicare and Medicaid beneficiaries more accessible and usable for analysis and is asking Congress for $110 million to accomplish it

You may also be interested in...



Part D Challenges Described By CMS Official Reflect A Mature Program

The main challenges facing Medicare Part D are those of a mature program as it enters its fifth year of providing prescription drug benefits

CIGNA's Limited Brand Coverage In Part D Gap Emphasizes Challenges

After several years of no national Medicare Part D prescription drug plan sponsors offering any kind of brand drug coverage in the donut hole, CIGNA's "Medicare Rx Plan Three" product offering in 2010 will give seniors suffering from hypothyroidism that option

CMS Defends Oral ESRD Drug Inclusion In Proposed Bundling Rule

In anticipation of objections to its proposal to include oral end-stage renal disease drugs currently covered under Medicare Part D in bundled payments for ESRD services, CMS offered an extensive justification for the action

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS051902

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel